A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

Completed · Phase 3

Conditions studied: Atopic Dermatitis

In brief

This study will evaluate crisaborole therapy once daily (QD) as a long-term topical maintenance therapy for the reduction of flare in responders to crisaborole twice daily (BID) treatment.

Key facts

Study ID
NCT04040192
Run by
Pfizer
People needed
620
Starts
2019-09-12
Expected to finish
2022-01-19
Last updated by the study team
2023-03-08

Who can join

Age: 0 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.